Related Experiment Video
Updated: Jun 13, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Microbiota in pediatric inflammatory bowel disease.
Andreas Schwiertz1, Manuela Jacobi, Julia-Stefanie Frick
1Institute of Microecology, Herborn, Germany. andreas.schwiertz@mikrooek.de
Children with Crohn's disease (CD) show altered gut bacteria, with lower levels of beneficial Faecalibacterium prausnitzii and bifidobacteria, and higher levels of Escherichia coli compared to controls.
Area of Science:
- Microbiology
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
Background:
- Gut microbiota plays a crucial role in maintaining intestinal homeostasis.
- Alterations in gut microbial composition are implicated in the pathogenesis of inflammatory bowel disease (IBD).
- Understanding these microbial changes in pediatric IBD is essential for developing targeted therapies.
Purpose of the Study:
- To investigate differences in gut microbiota composition between children with IBD and healthy controls.
- To explore the relationship between gut microbiota and disease activity in pediatric IBD.
- To identify specific bacterial groups associated with active versus inactive disease states.
Main Methods:
- A cohort of 69 children and adolescents with IBD and 25 healthy controls were recruited.
- Disease activity was assessed using validated pediatric indices for ulcerative colitis and Crohn's disease.
- Fecal microbiota composition was analyzed using real-time polymerase chain reaction to quantify specific bacterial groups.
Main Results:
- Children with active and inactive Crohn's disease (CD) exhibited significantly lower counts of Faecalibacterium prausnitzii and bifidobacteria.
- Patients with active CD showed increased levels of Escherichia coli compared to controls.
- While some decrease in bifidobacteria was noted in active IBD, significant changes were primarily observed in CD.
Conclusions:
- The gut microbiota in pediatric CD is characterized by a depletion of F. prausnitzii and an overgrowth of E. coli.
- These specific microbial alterations may contribute to the disease activity in pediatric Crohn's disease.
- Further research is warranted to elucidate the functional implications of these microbial shifts.
Related Concept Videos
Microbiota Modulation by Antibiotics
Dysbiosis of the Gut Microbiota
Microbiota of the Stomach and Small Intestine
Development of Human Microbiota
Inflammatory Bowel Disease III: Crohn's Disease
Microbiota of the Large Intestine